XORTX Therapeutics, Inc. (XRTX)
0.60
+0.01
(+1.59%)
USD |
NASDAQ |
Dec 19, 16:00
0.61
+0.01
(+1.67%)
After-Hours: 20:00
XORTX Therapeutics EPS Diluted (Quarterly): -0.1337 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -0.1032 |
| Aurinia Pharmaceuticals, Inc. | 0.232 |
| Edesa Biotech, Inc. | -0.3157 |
| Lexaria Bioscience Corp. | -0.1378 |
| Xenon Pharmaceuticals, Inc. | -1.147 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.6495M |
| Total Expenses (Quarterly) | 0.6495M |
| Enterprise Value | 3.042M |
| Earnings Yield | -78.35% |
| Normalized Earnings Yield | -125.60 |